Despite a rocky six months, Lockheed Martin (NYSE: LMT) closed its most recent session at $586.29, even as the average Wall Street price target sits at $628.21.
That consensus target implies roughly 7% upside from current levels, but Seaport Global analyst Richard Safran believes the stock is worth considerably more.
Safran lifted his price target to $756 from $664 while maintaining a Buy rating, implying close to 29% upside from where shares currently trade.
His thesis centers on re-acceleration in international procurement across PAC-3, HIMARS, and Javelin franchises, F-35 Block 4 normalization unlocking working capital, and free cash flow conversion supporting aggressive buybacks and dividend growth.
The broader analyst community remains more cautious, with ratings compiled at 2 Strong Buy, 4 Buy, 14 Hold, and 1 Sell, leaving the stock weighted firmly toward a Hold consensus.
Lockheed builds the F-35 fighter, PAC-3 and THAAD interceptors, Sikorsky helicopters, and much of the classified missile-defense architecture the Pentagon is actively scaling right now.
Global rearmament trends, the FY2027 budget request, and multi-year munitions contracts have created what many analysts describe as unprecedented demand for the company’s core product lines.
Yet the stock has largely stagnated over the past six months even as the company’s backlog exploded to a record $230.42 billion, built on $65 billion of new orders in the most recent quarter.
That disconnect between backlog growth and share price performance is precisely the opportunity Seaport Global is now betting on with Safran’s upgraded price target.
The pullback in shares traces directly to Q1 2026, when Lockheed reported EPS of $6.44 versus a $6.70 consensus estimate and posted free cash flow of -$291 million.
Operating cash flow collapsed from $1.41 billion to $220 million, and segment operating margin compressed from 11.6% to 10.1% on a $125 million unfavorable F-16 adjustment plus charges on C-130, CH-53K, and Seahawk programs.
Those results reopened investor anxiety around prior classified-program reach-forward losses that hit Aeronautics for $950 million in 2025 and $1.7 billion in Q4 2024.
F-35 deliveries falling to 19 in Q2 2026 from 50 a year earlier added further pressure, hardening the view that fixed-price execution risk may be structural rather than temporary.
The stock is down roughly 6.5% from the $626.83 level recorded at the Q4 filing in late January and sits close to 15% below its 52-week high of $687.50.
Q2 2026 provided the bull case with significant fresh ammunition, as Lockheed reported EPS of $7.94 against a $7.20 consensus, revenue of $20.06 billion up 10.5% year over year, and free cash flow of $2.92 billion.
Management raised full-year guidance to sales of $79.75 billion to $81.75 billion and EPS of $29.95 to $30.65, with segment operating profit expected to come in 28% higher than the prior year.
Analysts are watching the $35 billion multi-year THAAD contract and a seven-year PAC-3 framework as the metrics most likely to convert current Hold ratings into Buys heading into 2027.
Among its closest peers, RTX Corporation (NYSE: RTX) trades at $216.65 against a $229.82 consensus target for roughly 6% upside, with shares up 10.94% over six months and 19.01% year to date.
Northrop Grumman (NYSE: NOC) trades at $548.47 versus a $643.62 target for roughly 17% implied upside, though shares are down 19.86% over the past six months, making it the weakest performer in the group.
General Dynamics (NYSE: GD) sits at $382.43 against a $414.17 consensus target for about 8% upside, with shares up 15.09% year to date and analyst sentiment skewing constructive at 13 Buy or Strong Buy ratings.
Lockheed currently trades at a forward P/E of 19, which lines up cleanly with the guided EPS midpoint of roughly $30.30, suggesting the market is not pricing in any meaningful upside from the backlog conversion.
The bear case hinges on whether the classified reach-forward loss cycle is genuinely finished, as another charge above $500 million in Aeronautics would erase the 28% segment profit growth thesis entirely.
Supporting the constructive case are a $9.1 billion buyback authorization and 23 consecutive years of dividend hikes, which give long-term investors meaningful downside cushion even through another potentially lumpy quarter.
